DHT and Inflammation: What the Finasteride Comparison Found

A 2016 experiment reported that a blend of beta-sitosterol, thioctic acid and carnitine outperformed finasteride on certain cell markers. The interesting idea was to address androgen-related processes and inflammation together.

The result behind the headline

Chen and colleagues tested the blend in hair-follicle dermal-papilla cells and LNCaP prostate cells. It reduced disease-associated patterns of messenger RNA more strongly than finasteride under the assay conditions. Tests of protein levels supported the gene-expression findings.

That is a promising laboratory result for a combined approach. “Outperformed” describes the molecular response in cultured cells; the experiment did not compare hair growth in patients. The published abstract does not supply ingredient amounts, concentrations or numerical effect sizes.

Why include inflammation?

An earlier experiment tested a related preparation containing saw-palmetto extract, thioctic acid and carnitine in human skin cells. After researchers triggered an inflammatory response, the preparation reduced several inflammation-associated gene signals, including CCL17 and CXCL6. The full 2011 paper describes that experiment.

Together, the studies support exploring more than one biological target. They leave a practical question for a clinical trial: would a fully specified formulation produce better hair growth than targeting DHT alone?